Goodsurance

Policy & oversight

Medicare Trustees Hold Part A Depletion Date at 2033 as Projected Part D Spending Accelerates

The 2026 Medicare Trustees Report projects the hospital insurance trust fund will exhaust its reserves in 2033, one quarter earlier than last year's estimate, and sees Part D drug spending nearly doubling by 2035.

By the Goodsurance editorial teamJuly 6, 2026

The 2026 Medicare Trustees Report, released June 9, 2026, projects the Medicare Part A hospital insurance trust fund will be depleted in 2033, one quarter earlier than the 2025 report estimated. Depletion would not stop Medicare payments immediately; incoming payroll tax revenues would continue to cover a portion of scheduled benefits. Parts B and D are funded through general revenues and enrollee premiums, which carry no comparable depletion risk.

The report projects Medicare Part D prescription drug spending will nearly double, rising from approximately 181 billion dollars in 2025 to roughly 346 billion dollars by 2035, an average annual growth rate of about 6.7 percent. The Inflation Reduction Act expanded Part D coverage in ways that are expected to increase total program spending, including by capping annual out-of-pocket costs for enrollees and reducing cost-sharing in the catastrophic coverage phase, even as newly negotiated drug prices apply to selected medications.

CMS said the report reflects reduced cost growth on some measures compared to prior projections.

The Trustees publish this annual report each spring to give Congress and the public a current picture of Medicare's financial health. Any change to Medicare's financing requires an act of Congress; the report does not call for immediate benefit adjustments.

In plain words

Every year, Medicare leaders put out a report on how the program is doing with money. The 2026 report came out in June. It says the fund that pays for hospital care, called Part A, could run out of money in 2033. That is a little sooner than they thought last year. Running out of money does not mean Medicare stops. It means Medicare might have to cover less than the full bill for some care. The report also says spending on prescription drugs could almost double by 2035. This is partly because Medicare now covers more of the drug costs for its members. Congress would need to act to fix any funding gap before it happens.

Source: CMS
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

OIG Found More Than 15 Million Dollars in Medicare Payments Where Emergency Room Billing Codes Were Used at Non-Emergency Sites

A March 2026 federal audit identified improper and potentially improper Medicare payments made when physicians and hospitals used emergency department billing codes for care not actually delivered in an emergency department, and found that Medicare lacked automated safeguards to catch the mismatches.

August 8, 2026

Policy & oversight

Federal Audit Found at Least 4.7 Million Dollars in Medicare Overpayments at an Arkansas Hospital

An OIG audit of Jefferson Regional Medical Center found a high rate of billing errors on claims flagged as elevated risk, producing an estimated 4.7 million dollars in improper Medicare payments. The hospital disputed most of the findings.

August 7, 2026

Policy & oversight

CMS Publishes Plan to Speed Medicare Coverage for Breakthrough Medical Devices

A new pathway would give FDA-cleared breakthrough devices a national Medicare coverage decision within weeks of regulatory approval, rather than waiting years under the standard process.

August 7, 2026

Policy & oversight

Federal Audit Found 97 Cybersecurity Gaps in Medicare Billing Contractors for Fiscal Year 2024, Though the Most Serious Deficiencies Declined

An OIG annual report to Congress found information security deficiencies across all seven Medicare administrative contractors in fiscal year 2024, while noting that high-risk and moderate-risk gaps fell compared with the prior year.

August 6, 2026

Policy & oversight

CMS Published Second-Quarter 2026 Drug Coding Decisions That Shape How Medicare Identifies and Pays for New Medicines

The quarterly HCPCS drug coding update, posted July 29 and highlighted in the August 6 MLN Connects newsletter, determines which new medications and biologicals get a dedicated Medicare billing code.

August 6, 2026

Policy & oversight

CMS Sets a Sunset Date for the NTAP Alternative Track for Breakthrough Devices and Advances the RAPID Pathway

The fiscal year 2027 hospital payment final rule phases out the alternative NTAP track that breakthrough-designated devices used to qualify for Medicare reimbursement, while a new CMS-FDA program called RAPID is positioned to take its place.

August 5, 2026